Sanctus Drugs & Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 23-10-2024
- Paid Up Capital ₹ 2.48 Cr
as on 23-10-2024
- Company Age 40 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.90 Cr
as on 23-10-2024
- Satisfied Charges ₹ 1.41 Cr
as on 23-10-2024
- Revenue -42.95%
(FY 2023)
- Profit -80.06%
(FY 2023)
- Ebitda -44.20%
(FY 2023)
- Net Worth 178.93%
(FY 2023)
- Total Assets 95.04%
(FY 2023)
About Sanctus Drugs & Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.48 Cr.
The company currently has active open charges totaling ₹5.90 Cr. The company has closed loans amounting to ₹1.41 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Jain and Rahul Jain serve as directors at the Company.
- CIN/LLPIN
U24232MP1984PTC002519
- Company No.
002519
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Aug 1984
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sanctus Drugs & Pharmaceuticals Pvt Ltd offer?
Sanctus Drugs & Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Common Disease Medicines, IV Fluids, Cardiovascular Drugs & Medication, Kidney Drugs, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup.
Who are the key members and board of directors at Sanctus Drugs & Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Jain  | Director | 22-Sep-1996 | Current |
| Rahul Jain | Director | 30-Jun-2020 | Current |
Financial Performance of Sanctus Drugs & Pharmaceuticals.
Sanctus Drugs & Pharmaceuticals Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 42.95% decrease. The company also saw a substantial fall in profitability, with a 80.06% decrease in profit. The company's net worth Soared by an impressive increase of 178.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanctus Drugs & Pharmaceuticals?
In 2023, Sanctus Drugs & Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 23 Mar 2023 | ₹0.98 M | Open |
Hdfc Bank Limited Creation Date: 18 Mar 2023 | ₹5.80 Cr | Open |
State Bank Of India Creation Date: 21 Apr 2017 | ₹0.80 M | Satisfied |
How Many Employees Work at Sanctus Drugs & Pharmaceuticals?
Unlock and access historical data on people associated with Sanctus Drugs & Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanctus Drugs & Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanctus Drugs & Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
